Source:http://linkedlifedata.com/resource/pubmed/id/17936228
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
2007-10-15
|
pubmed:abstractText |
HCV chronic infection leads to liver diseases and also to a wide range of extrahepatic disorders including benign, but pre-lymphomatous forms (mixed cryoglobulinemia) to frank hematological neoplasia (non-Hodgkin's lymphoma). Recent data showed the involvement of p53 superfamily members in the pathogenesis of different lymphatic malignancies. In fact, tymomas and a subset of non-Hodgkin's lymphomas (NHLs) express high levels of p63. Thus, we analyzed whether alterations in p53 superfamily gene expression are observable in B lymphocytes isolated from HCV-infected patients with and without lymphoproliferative disorders. We showed, by real-time PCR, a significant induction of DNp63 mRNAs in B lymphocytes obtained from HCV-positive low grade non-Hodgkin's lymphoma patients. Since our current understanding of HCV proteins emphasizes the ability of the HCV core protein to deregulate the expression and activity of p53-related proteins, we established different B lymphocyte cell lines (Wil2-ns, Daudi and Ramos) stably expressing HCV core protein, in order to investigate the possible involvement of the viral protein in the upregulation of DNp63 in B lymphocytes. The analysis of p63 family transcripts showed no transcriptional changes for the p63 TA isoforms, whereas an increase (>5 times) of DNp63 mRNA occurred. In all cell lines, this abnormal expression was associated with a significant increase of cell proliferation that was specifically inhibited by silencing DNp63 mRNA. These findings suggest a pathogenetic role of the HCV core in HCV-related lymphomagenesis, through the induction of DNp63's pro-proliferative effects.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
1878-3562
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
39 Suppl 1
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
S72-5
|
pubmed:dateRevised |
2009-5-20
|
pubmed:meshHeading |
pubmed-meshheading:17936228-Apoptosis,
pubmed-meshheading:17936228-B-Lymphocytes,
pubmed-meshheading:17936228-Cell Division,
pubmed-meshheading:17936228-Cells, Cultured,
pubmed-meshheading:17936228-Hepacivirus,
pubmed-meshheading:17936228-Humans,
pubmed-meshheading:17936228-Membrane Proteins,
pubmed-meshheading:17936228-RNA, Messenger,
pubmed-meshheading:17936228-Reverse Transcriptase Polymerase Chain Reaction,
pubmed-meshheading:17936228-Up-Regulation,
pubmed-meshheading:17936228-Viral Core Proteins
|
pubmed:year |
2007
|
pubmed:articleTitle |
Hepatitis C virus core protein enhances B lymphocyte proliferation.
|
pubmed:affiliation |
Laboratory of Molecular Virology and Oncology, Fondazione A. Cesalpino, University of Rome La Sapienza, Rome, Italy.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|